NCT06043232View on ClinicalTrials.gov

MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for Gliomas

RecruitingOBSERVATIONAL

Enrollment

360

Participants

Timeline

Start Date

September 30, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Glioma

Interventions

BIOLOGICAL

DC vaccine

DC vaccine produced by the Team

Trial Locations (1)

200040

RECRUITING

Huashan Hospital，Fudan University, Shanghai

All Listed Sponsors

lead

Huashan Hospital

OTHER